FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048794805> ?p ?o ?g. }

• W2048794805 endingPage "460" @default.
• W2048794805 startingPage "453" @default.
• W2048794805 abstract "We initiated at Hospital de Mulhouse a prospective phase II study to assess a split-course concurrent radiochemotherapy in locally advanced non-small cell lung cancer.From March 1996 to December 1997, 28 patients were included in our study. All patients had a stage III cancer. The chemotherapy scheduled included vinorelbine (20 mg/m2/d, d1 and d5), cisplatin (20 mg/m2/d, from d1 to d5), and 5-Fluorouracil (350 mg/m2/d, from d1 to d5 by continuous infusion). The planned irradiation dose was 12.5 Gy per week with one daily fraction of 2.5 Gy from d1 to d5. Cycles were repeated every four weeks, for four cycles (50 Gy). Patients with a partial or complete response were proposed a fifth cycle.Of the 28 patients of the study, only 27 were analysed; one patient had a metastatic disease at diagnosis. Major hematologic toxicity occurred in 26% of the patients. One to five cycles of chemoradiotherapy were administrated per patient (median: four). Four patients had received fewer than three cycles and their responses were not assessable. Of the 23 patients assessed, 12 responses (52%) were observed, three CR (13%) and nine PR (39%). Median follow-up was 14 months, and median survival 13.5 months. One- and two-year survival rates were respectively 63% and 14%. Local control rates was 11%, and 44% of the patients had a metastatic evolution.Very preliminary results of this phase II study are disappointing, and quite inferior to the published results using chemoradiotherapy with conventional or hyperfractionated radiotherapy. Hematologic toxicity is restrictive. This type of chemoradiotherapy cannot be recommended." @default.
• W2048794805 created "2016-06-24" @default.
• W2048794805 creator A5004829147 @default.
• W2048794805 creator A5005563500 @default.
• W2048794805 creator A5020131898 @default.
• W2048794805 creator A5028402286 @default.
• W2048794805 creator A5032742553 @default.
• W2048794805 creator A5040896813 @default.
• W2048794805 creator A5051812041 @default.
• W2048794805 creator A5053768591 @default.
• W2048794805 creator A5054682002 @default.
• W2048794805 creator A5060369019 @default.
• W2048794805 creator A5061336291 @default.
• W2048794805 creator A5061546502 @default.
• W2048794805 creator A5065511385 @default.
• W2048794805 creator A5083630382 @default.
• W2048794805 creator A5090078704 @default.
• W2048794805 date "1999-11-01" @default.
• W2048794805 modified "2023-10-13" @default.
• W2048794805 title "Chimioradiothérapie en split course dans les carcinomes bronchiques non à petites cellules de stade III : résultats préliminaires d'une étude de phase II" @default.
• W2048794805 cites W1870429510 @default.
• W2048794805 cites W1883860222 @default.
• W2048794805 cites W1963786241 @default.
• W2048794805 cites W1964402113 @default.
• W2048794805 cites W1978156658 @default.
• W2048794805 cites W2005722731 @default.
• W2048794805 cites W2007242645 @default.
• W2048794805 cites W2016263166 @default.
• W2048794805 cites W2019926572 @default.
• W2048794805 cites W2020687877 @default.
• W2048794805 cites W2026788229 @default.
• W2048794805 cites W2028510990 @default.
• W2048794805 cites W2031833724 @default.
• W2048794805 cites W2051767374 @default.
• W2048794805 cites W2073871873 @default.
• W2048794805 cites W2074654613 @default.
• W2048794805 cites W2082208022 @default.
• W2048794805 cites W2105150213 @default.
• W2048794805 cites W2128746268 @default.
• W2048794805 cites W2129793485 @default.
• W2048794805 cites W2138310931 @default.
• W2048794805 cites W2138477625 @default.
• W2048794805 cites W2142764975 @default.
• W2048794805 cites W2155053061 @default.
• W2048794805 cites W2176864701 @default.
• W2048794805 cites W2226077283 @default.
• W2048794805 cites W2261537552 @default.
• W2048794805 cites W2312703485 @default.
• W2048794805 cites W3041047318 @default.
• W2048794805 cites W4239714259 @default.
• W2048794805 doi "https://doi.org/10.1016/s1278-3218(00)88251-7" @default.
• W2048794805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10630157" @default.
• W2048794805 hasPublicationYear "1999" @default.
• W2048794805 type Work @default.
• W2048794805 sameAs 2048794805 @default.
• W2048794805 citedByCount "4" @default.
• W2048794805 countsByYear W20487948052016 @default.
• W2048794805 countsByYear W20487948052022 @default.
• W2048794805 crossrefType "journal-article" @default.
• W2048794805 hasAuthorship W2048794805A5004829147 @default.
• W2048794805 hasAuthorship W2048794805A5005563500 @default.
• W2048794805 hasAuthorship W2048794805A5020131898 @default.
• W2048794805 hasAuthorship W2048794805A5028402286 @default.
• W2048794805 hasAuthorship W2048794805A5032742553 @default.
• W2048794805 hasAuthorship W2048794805A5040896813 @default.
• W2048794805 hasAuthorship W2048794805A5051812041 @default.
• W2048794805 hasAuthorship W2048794805A5053768591 @default.
• W2048794805 hasAuthorship W2048794805A5054682002 @default.
• W2048794805 hasAuthorship W2048794805A5060369019 @default.
• W2048794805 hasAuthorship W2048794805A5061336291 @default.
• W2048794805 hasAuthorship W2048794805A5061546502 @default.
• W2048794805 hasAuthorship W2048794805A5065511385 @default.
• W2048794805 hasAuthorship W2048794805A5083630382 @default.
• W2048794805 hasAuthorship W2048794805A5090078704 @default.
• W2048794805 hasConcept C126322002 @default.
• W2048794805 hasConcept C141071460 @default.
• W2048794805 hasConcept C146357865 @default.
• W2048794805 hasConcept C151730666 @default.
• W2048794805 hasConcept C2776256026 @default.
• W2048794805 hasConcept C2776694085 @default.
• W2048794805 hasConcept C2778239845 @default.
• W2048794805 hasConcept C2778424827 @default.
• W2048794805 hasConcept C2780350996 @default.
• W2048794805 hasConcept C2780456651 @default.
• W2048794805 hasConcept C2989005 @default.
• W2048794805 hasConcept C31760486 @default.
• W2048794805 hasConcept C71924100 @default.
• W2048794805 hasConcept C86803240 @default.
• W2048794805 hasConcept C90924648 @default.
• W2048794805 hasConceptScore W2048794805C126322002 @default.
• W2048794805 hasConceptScore W2048794805C141071460 @default.
• W2048794805 hasConceptScore W2048794805C146357865 @default.
• W2048794805 hasConceptScore W2048794805C151730666 @default.
• W2048794805 hasConceptScore W2048794805C2776256026 @default.
• W2048794805 hasConceptScore W2048794805C2776694085 @default.
• W2048794805 hasConceptScore W2048794805C2778239845 @default.
• W2048794805 hasConceptScore W2048794805C2778424827 @default.
• W2048794805 hasConceptScore W2048794805C2780350996 @default.

• next